Metastatic Uveal Melanoma Latest Advances

Longitudinal ctDNA monitoring in patients with metastatic uveal melanoma undergoing isolated hepatic perfusion in combination with ipilimumab and nivolumab.

Journal: Immuno-oncology technology

Published: December 09, 2025

Metastatic Uveal Melanoma Surveillance: A Delphi Panel Consensus.

Journal: Cancers

Published: November 27, 2025

Characterization of Early Metastatic Subpopulations in Uveal Melanoma: Single-Cell Insights Into SPP1+ Cells and Their Interactions With Macrophages.

Journal: Investigative ophthalmology & visual science

Published: November 17, 2025

Survival Outcome After Percutaneous Hepatic Perfusion with High-Dose Melphalan for Liver-Dominant Metastatic Uveal Melanoma: A 10-Year Single-Center Experience.

Journal: Cancers

Published: October 30, 2025

Blood-Based Cell-Free DNA in Ophthalmic Oncology.

Journal: Translational vision science & technology

Published: October 06, 2025

Real-World Outcomes of Ipilimumab-Nivolumab vs. Anti-PD-1 Monotherapy in Metastatic Uveal Melanoma: A Single-Center Retrospective Study.

Journal: Cancers

Published: September 25, 2025

Checkpoint Blockade Efficacy in Uveal Melanoma Is Linked to Tumor Immunity, CD28, and CCL8.

Journal: International journal of molecular sciences

Published: September 21, 2025

Four Months of Exercise Intervention Improved Visuomotor, Functional and Cardiorespiratory Capacity in a Patient with Metastatic Uveal Melanoma.

Journal: Reports (MDPI)

Published: September 15, 2025

Multi-responsive nanocomposite hydrogel for synergistic photothermal-chemotherapy to prevent postoperative recurrence and metastasis of uveal melanoma.

Journal: Materials today. Bio

Published: September 02, 2025

Clinical and radiomics parameter prognostication in metastatic uveal melanoma patients treated with hepatic arterial infusion chemotherapy.

Journal: The oncologist

Published: August 28, 2025

Letter Re: "Molecular determinants of survival in metastatic uveal melanoma: The impact of SF3B1 mutations".

Journal: European journal of cancer (Oxford, England : 1990)

Published: August 27, 2025

Montelukast as a novel therapeutic approach in metastatic uveal melanoma harboring a CYSLTR2 mutation: a translational case report.

Journal: ESMO open

Published: August 13, 2025